دورية أكاديمية

Improvement of Inflammation and Abnormal Vascularization by TSP1 Treatment Combined with ADSCs Transplantation in Mice with Induced Polycystic Ovary Syndrome.

التفاصيل البيبلوغرافية
العنوان: Improvement of Inflammation and Abnormal Vascularization by TSP1 Treatment Combined with ADSCs Transplantation in Mice with Induced Polycystic Ovary Syndrome.
المؤلفون: Ju, Mingyan, Wang, Zihan, Yang, Weiwei, Sui, Zhenhua, Wang, Wenjing, Sun, Kuikui, Ren, Chenchun
المصدر: Advanced Biology; Feb2024, Vol. 8 Issue 2, p1-14, 14p
مصطلحات موضوعية: POLYCYSTIC ovary syndrome, INDUCED ovulation, FEMALE reproductive organ diseases, MESENCHYMAL stem cells, INFLAMMATION, ENDOCRINE diseases, OVARIAN follicle
مستخلص: Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disease with a certain degree of chronic inflammation and abnormal ovarian angiogenesis in reproductive women. Mesenchymal stem cells (MSCs) have potent immunomodulatory properties to regulate ovarian function, while thrombospondin 1 (TSP1) improves the abnormal formation of ovarian vessels. The present study investigated the efficacy of the combined use of adipose‐derived mesenchymal stem cells (ADSCs) and TSP1 in PCOS mice. The PCOS model is established using dehydroepiandrosterone (DHEA) by subcutaneous injection. Ovarian apoptosis is assessed using terminal deoxynucleotidyl transferase dUTP nick‐end labeling (TUNEL). Real‐time quantitative PCR (RT‐PCR) and western blotting are used to detect the expression of inflammatory factors and the levels of angiogenesis‐related factors in ovarian tissues. Inflammatory cells count and ovarian angiogenesis are evaluated by immunofluorescence staining. This research shows that TSP1 and ADSCs treatment can significantly reduce the inflammatory state of PCOS mice, relieve the degree of ovarian cell apoptosis, optimize the ovarian histological manifestations, and restore the levels of related hormones. The proportion of CD31‐positive cells in PCOS mice returned to near‐normal levels. The synergistic use of ADSCs and TSP1 therapy can exert a more impressive effect by inhibiting the ovarian inflammatory response and regulating the balance of angiogenesis than the single application in PCOS mice. [ABSTRACT FROM AUTHOR]
Copyright of Advanced Biology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:27010198
DOI:10.1002/adbi.202300451